Skip to main content

Neurocrine Licenses Genedata s Expressionist for Biomarker Discovery

NEW YORK, Dec. 7, (GenomeWeb News) - Biopharmaceutical company Neurocrine Biosciences has licensed Genedata's Expressionist for biomarker discovery and in silico prediction, Genedata said today.


Neurocrine will use Expressionist in a pre-clinical discovery program focusing on neurological and endocrine related diseases and disorders, Genedata said.


Scientists at Neurocrine have already used Expressionist to process and evaluate over 1,500 microarrays, said Bill Wilson, Neurocrine's head of information technology, in a statement.


Financial details were not disclosed.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.